Hsbc Holdings PLC Ionis Pharmaceuticals Inc Transaction History

Hsbc Holdings PLC

15 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 12, 2024	BUY	$36.45 - $47.7 $194,132 - $254,050	5,326 New	5,326 $253,000
Q1 2023 May 15, 2023	BUY	$33.58 - $41.2 $222,400 - $272,867	6,623 New	6,623 $236,000
Q2 2022 Aug 11, 2022	BUY	$31.71 - $43.0 $1.29 Million - $1.75 Million	40,609 Added 615.57%	47,206 $1.78 Million
Q1 2022 May 16, 2022	BUY	$29.88 - $37.04 $197,118 - $244,352	6,597 New	6,597 $242,000
Q3 2021 Nov 12, 2021	SELL	$33.54 - $40.55 $316,449 - $382,589	-9,435 Closed	0 $0
Q2 2021 Aug 13, 2021	SELL	$34.54 - $47.25 $172,009 - $235,305	-4,980 Reduced 34.55%	9,435 $376,000
Q1 2021 May 14, 2021	SELL	$42.51 - $63.78 $124,086 - $186,173	-2,919 Reduced 16.84%	14,415 $648,000
Q4 2020 Feb 12, 2021	SELL	$45.3 - $60.27 $1.17 Million - $1.56 Million	-25,841 Reduced 59.85%	17,334 $980,000
Q3 2020 Nov 12, 2020	BUY	$47.45 - $62.95 $1.46 Million - $1.93 Million	30,731 Added 246.95%	43,175 $2.06 Million
Q2 2020 Aug 14, 2020	BUY	$46.85 - $61.05 $52,940 - $68,986	1,130 Added 9.99%	12,444 $734,000
Q1 2020 May 15, 2020	SELL	$41.6 - $63.4 $1.59 Million - $2.42 Million	-38,120 Reduced 77.11%	11,314 $536,000
Q4 2019 Feb 14, 2020	BUY	$53.85 - $65.27 $1.38 Million - $1.68 Million	25,707 Added 108.34%	49,434 $3.02 Million
Q3 2019 Nov 14, 2019	BUY	$59.06 - $72.15 $717,401 - $876,406	12,147 Added 104.9%	23,727 $1.42 Million
Q2 2019 Aug 13, 2019	BUY	$62.09 - $86.14 $202,972 - $281,591	3,269 Added 39.33%	11,580 $745,000
Q1 2019 May 15, 2019	BUY	$52.92 - $81.17 $439,818 - $674,603	8,311 New	8,311 $675,000

403

136M

862K

582K

Ticker IONS
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 141,940,992
Market Cap $5.35B
Description
Ionis Pharmaceuticals, Inc. discovers and develops RNA-targeted therapeutics in the United States. The company offers SPINRAZA for spinal muscular atrophy (SMA) in pediatric and adult patients; TEGSEDI, an injection for the treatment of polyneuropathy of hereditary transthyretin-mediated amyloidosis in adults; and WAYLIVRA, a treatment for famil...

Get notified when there are updates to the investment portfolio of Hsbc Holdings PLC, based on Form 13F filings with the SEC.

Stay updated on Hsbc Holdings PLC with notifications on news.